Concepedia

B.K. Ambati

BA

Statistics

Publications

8

Citations

516

H-Index

8

Active since

2006

Affiliations

University of Utah(Current)

Eye Institute of Utah

Cleveland Eye Clinic

Augusta University

Cleveland Clinic

B.K. Ambati is an author at University of Utah specializing in medicine, angiogenesis, and cell signaling.

Publications per year

2006–2014

8

Publications

8

Intravenous transferrin, RGD peptide and dual-targeted nanoparticles enhance anti-VEGF intraceptor gene delivery to laser-induced CNV

SanjeetKumar Singh, H. E. Grossniklaus, Seong Jae Kang et al. · Gene Therapy · 2009 · 201 citations · Full text

, , +17

Soluble vascular endothelial growth factor receptor-1 contributes to the corneal antiangiogenic barrier

B.K. Ambati, Emily J Patterson, Pooja D. Jani et al. · British Journal of Ophthalmology · 2006 · 84 citations · Full text

, , +15

Effect of TGFβ and PDGF-B blockade on corneal myofibroblast development in mice

Vivek Singh, Marcony R. Santhiago, F.L. Barbosa et al. · Experimental Eye Research · 2011 · 75 citations

, , +14

TGFβ and PDGF-B signaling blockade inhibits myofibroblast development from both bone marrow-derived and keratocyte-derived precursor cells in vivo

Vivek Singh, Ritika Jaini, André A. M. Torricelli et al. · Experimental Eye Research · 2014 · 62 citations

, , +9

Tetramethylpyrazine-mediated suppression of C6 gliomas involves inhibition of chemokine receptor CXCR4 expression

Keming Yu, Zhao Chen, Xueke Pan et al. · Oncology Reports · 2012 · 33 citations · Full text

, , +16

1–5 of 8